Envoy Medical, Inc. COCH
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -5.13% | 12.95% | -42.62% | -8.76% | -44.16% |
| Total Depreciation and Amortization | -12.94% | 19.67% | 66.67% | 55.10% | 102.38% |
| Total Amortization of Deferred Charges | -4.07% | -8.10% | -5.04% | -9.26% | -8.55% |
| Total Other Non-Cash Items | 8.88% | -3,011.63% | 256.55% | -39.93% | 166.40% |
| Change in Net Operating Assets | -981.82% | -182.21% | 108.63% | -38.55% | -66.23% |
| Cash from Operations | -22.33% | -62.71% | -11.67% | -65.12% | 4.00% |
| Capital Expenditure | -500.00% | -- | -132.21% | 100.00% | 99.87% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -500.00% | -- | -132.21% | 100.00% | 99.87% |
| Total Debt Issued | -- | -- | -100.00% | -100.00% | 100.00% |
| Total Debt Repaid | 9.75% | 10.73% | 10.33% | -45.11% | 9.92% |
| Issuance of Common Stock | -62.99% | -- | 6,419.05% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | 100.00% | -- |
| Other Financing Activities | -- | -- | 53.73% | -63.59% | -- |
| Cash from Financing | -102.46% | 675.86% | 7.53% | -56.04% | 98.30% |
| Foreign Exchange rate Adjustments | 50.00% | -116.67% | 100.00% | 0.00% | -100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -22,188.00% | 12,680.12% | -82.70% | -164.64% | 99.22% |